Infertility Treatment Market By Procedure Type (Assisted Reproductive Technology {In Vitro Fertilization, Intracytoplasmic Sperm Injection, Gamete Donation}, Artificial Insemination {Intrauterine Insemination, Intracervical Insemination, Intratubal Insemination}, Fertility Surgeries {Laparoscopy, Hysteroscopy, Myomectomy, Tubal Ligation Reversal, Varicocelectomy}, Others), By Infertility Cause (Female Infertility Causes {Ovulatory Disorders, Tubal Factors, Endometriosis, Uterine Disorders, Advanced Maternal Age}, Male Infertility Causes {Low Sperm Count, Motility Issues, Structural Abnormalities, Hormonal Disorders}), By Technology (Conventional Techniques, Advanced Techniques {Time-Lapse Imaging, Artificial Intelligence in IVF, Genetic Testing in Embryos}), By Diagnostic Type (Female Infertility Diagnosis {Ovulation Testing, Endometrial and Uterine Tests, Ovarian Reverse Testing, Others}, Male Infertility Diagnosis {Semen Analysis, Post-Ejaculation Urinalysis, Testicular Biopsy, Others}, Others) and By End User (Fertility Clinics, Hospitals, Research Centres, Cryobanks), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Infertility Treatment Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Increasing prevalence of infertility due to lifestyle changes, delayed family planning, and health issues

3.2.2. Growing awareness about infertility treatment options and advancements in assisted reproductive technologies

3.2.3. Rising demand for in-vitro fertilization (IVF) and intrauterine insemination (IUI) procedures globally

3.3. Key industry pitfalls & challenges

3.3.1. High costs associated with infertility treatments, limiting access for middle and lower-income populations

3.3.2. Ethical and religious concerns surrounding assisted reproductive technologies in certain cultures

3.3.3. Risks and complications associated with multiple pregnancies and overstimulation during treatments

3.4. Market Opportunities

3.4.1. Development of innovative and minimally invasive infertility treatments to attract more patients

3.4.2. Expansion of telemedicine services offering consultations and guidance for infertility treatments remotely

3.4.3. Research into advanced genetic testing and embryo screening techniques to improve treatment outcomes

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Infertility Treatment Market, Procedure Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Procedure Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Assisted Reproductive Technology

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.2. In Vitro Fertilization (IVF)

4.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.3. Intracytoplasmic Sperm Injection (ICSI)

4.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.4. Gamete Donation

4.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Artificial Insemination

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.2. Intrauterine Insemination (IUI)

4.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.3. Intracervical Insemination

4.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.4. Intratubal Insemination

4.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Fertility Surgeries

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.2. Laparoscopy

4.4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.3. Hysteroscopy

4.4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.4. Myomectomy

4.4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.5. Tubal Ligation Reversal

4.4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.6. Varicocelectomy

4.4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Others

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Infertility Treatment Market, Infertility Cause Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Infertility Cause, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Female Infertility Causes

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.2. Ovulation Disorders

5.2.2.1. Market Size and Forecast, 2025-2035(USD Billion)

5.2.3. Tubal Factors

5.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.4. Endometriosis

5.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.5. Uterine Disorders

5.2.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.6. Advanced Maternal Age

5.2.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Male Infertility Causes

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3.2. Low Sperm Count

5.3.2.1. Market Size and Forecast, 2025-2035(USD Billion)

5.3.3. Motility Issues

5.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3.4. Structural Abnormalities

5.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3.5. Hormonal Disorders

5.3.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Infertility Treatment Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Conventional Techniques

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Advanced Techniques

6.3.1. Market Size and Forecast, 2025-2035(USD Billion)

6.3.2. Time-Lapse Imaging

6.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3.3. Artificial Intelligence in IVF

6.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3.4. Genetic Testing in Embryos

6.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Infertility Treatment Market, Diagnostic Type Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Diagnostic Type, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Female Infertility Diagnosis

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.2. Ovulation Testing

7.2.2.1. Market Size and Forecast, 2025-2035(USD Billion)

7.2.3. Endometrial and Uterine Tests

7.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.4. Ovarian Reverse Testing

7.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.5. Others

7.2.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Male Infertility Diagnosis

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3.2. Semen Analysis

7.3.2.1. Market Size and Forecast, 2025-2035(USD Billion)

7.3.3. Post-Ejaculation Urinalysis

7.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3.4. Testicular Biopsy

7.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3.5. Others

7.3.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Others

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Infertility Treatment Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Fertility Clinics

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Hospitals

8.3.1. Market Size and Forecast, 2025-2035(USD Billion)

8.4. Research Centres

8.4.1. Market Size and Forecast, 2025-2035(USD Billion)

8.5. Cryobanks

8.5.1. Market Size and Forecast, 2025-2035(USD Billion)

9. Infertility Treatment Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Procedure Type, 2025-2035

9.2.3. North America Market Revenue, By Infertility Cause, 2025-2035

9.2.4. North America Market Revenue, By Technology, 2025-2035

9.2.5. North America Market Revenue, By Diagnostic Type, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Procedure Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Infertility Cause, 2025-2035

9.2.7.3. U.S. Market Revenue, By Technology, 2025-2035

9.2.7.4. U.S. Market Revenue, By Diagnostic Type, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Procedure Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Infertility Cause, 2025-2035

9.2.8.3. Canada Market Revenue, By Technology, 2025-2035

9.2.8.4. Canada Market Revenue, By Diagnostic Type, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Procedure Type, 2025-2035

9.3.3. Europe Market Revenue, By Infertility Cause, 2025-2035

9.3.4. Europe Market Revenue, By Technology, 2025-2035

9.3.5. Europe Market Revenue, By Diagnostic Type, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Procedure Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Infertility Cause, 2025-2035

9.3.7.3. Germany Market Revenue, By Technology, 2025-2035

9.3.7.4. Germany Market Revenue, By Diagnostic Type, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Procedure Type, 2025-2035

9.3.8.2. France Market Revenue, By Infertility Cause, 2025-2035

9.3.8.3. France Market Revenue, By Technology, 2025-2035

9.3.8.4. France Market Revenue, By Diagnostic Type, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Procedure Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Infertility Cause, 2025-2035

9.3.9.3. U.K. Market Revenue, By Technology, 2025-2035

9.3.9.4. U.K. Market Revenue, By Diagnostic Type, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Procedure Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Infertility Cause, 2025-2035

9.3.10.3. Italy Market Revenue, By Technology, 2025-2035

9.3.10.4. Italy Market Revenue, By Diagnostic Type, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Procedure Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Infertility Cause, 2025-2035

9.3.11.3. Spain Market Revenue, By Technology, 2025-2035

9.3.11.4. Spain Market Revenue, By Diagnostic Type, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Procedure Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Infertility Cause, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Technology, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Diagnostic Type, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Procedure Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Infertility Cause, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Diagnostic Type, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Procedure Type, 2025-2035

9.4.7.2. China Market Revenue, By Infertility Cause, 2025-2035

9.4.7.3. China Market Revenue, By Technology, 2025-2035

9.4.7.4. China Market Revenue, By Diagnostic Type, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Procedure Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Infertility Cause, 2025-2035

9.4.8.3. Japan Market Revenue, By Technology, 2025-2035

9.4.8.4. Japan Market Revenue, By Diagnostic Type, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Procedure Type, 2025-2035

9.4.9.2. India Market Revenue, By Infertility Cause, 2025-2035

9.4.9.3. India Market Revenue, By Technology, 2025-2035

9.4.9.4. India Market Revenue, By Diagnostic Type, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Procedure Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Infertility Cause, 2025-2035

9.4.10.3. Australia Market Revenue, By Technology, 2025-2035

9.4.10.4. Australia Market Revenue, By Diagnostic Type, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Procedure Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Infertility Cause, 2025-2035

9.4.11.3. South Korea Market Revenue, By Technology, 2025-2035

9.4.11.4. South Korea Market Revenue, By Diagnostic Type, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Procedure Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Infertility Cause, 2025-2035

9.4.12.3. Singapore Market Revenue, By Technology, 2025-2035

9.4.12.4. Singapore Market Revenue, By Diagnostic Type, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Procedure Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Infertility Cause, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Diagnostic Type, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Procedure Type, 2025-2035

9.5.3. Latin America Market Revenue, By Infertility Cause, 2025-2035

9.5.4. Latin America Market Revenue, By Technology, 2025-2035

9.5.5. Latin America Market Revenue, By Diagnostic Type, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Procedure Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Infertility Cause, 2025-2035

9.5.7.3. Brazil Market Revenue, By Technology, 2025-2035

9.5.7.4. Brazil Market Revenue, By Diagnostic Type, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Procedure Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Infertility Cause, 2025-2035

9.5.8.3. Argentina Market Revenue, By Technology, 2025-2035

9.5.8.4. Argentina Market Revenue, By Diagnostic Type, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Procedure Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Infertility Cause, 2025-2035

9.5.9.3. Mexico Market Revenue, By Technology, 2025-2035

9.5.9.4. Mexico Market Revenue, By Diagnostic Type, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Procedure Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Infertility Cause, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Technology, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Diagnostic Type, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Procedure Type, 2025-2035

9.6.3. MEA Market Revenue, By Infertility Cause, 2025-2035

9.6.4. MEA Market Revenue, By Technology, 2025-2035

9.6.5. MEA Market Revenue, By Diagnostic Type, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Procedure Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Infertility Cause, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Technology, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Diagnostic Type, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Procedure Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Infertility Cause, 2025-2035

9.6.8.3. South Africa Market Revenue, By Technology, 2025-2035

9.6.8.4. South Africa Market Revenue, By Diagnostic Type, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East &Africa

9.6.9.1. Rest of Middle East &Africa Market Revenue, By Procedure Type, 2025-2035

9.6.9.2. Rest of Middle East& Africa Market Revenue, By Infertility Cause, 2025-2035

9.6.9.3. Rest of Middle East &Africa Market Revenue, By Technology, 2025-2035

9.6.9.4. Rest of Middle East & Africa Market Revenue, By Diagnostic Type, 2025-2035

9.6.9.5. Rest of Middle East &Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Merck Group

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Ferring Pharmaceuticals

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. IVF Fertility Centers of America

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. CooperSurgical

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Genea

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Vitrolife

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Cook Medical

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Thermo Fisher Scientific

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. OvaScience

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. Medi IVF

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Becton Dickinson

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Koo Fertility

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Ginkgo Bioworks

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Cochlear Limited

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. RMA of New York

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis